Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

7.060 -0.140 (-1.94%)

Official Closing Price Updated: 4:10 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Merck, the Dow's hottest stock, gets set to report Q4 financials

January 08, 2024

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

Via MarketBeat

Topics Stocks

Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook

January 08, 2024

From Organon & Co.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts ↗

December 27, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Analyst Expectations for Organon's Future ↗

November 22, 2023

Via Benzinga

Organon: Dividend Insights ↗

November 07, 2023

Via Benzinga

Analyst Ratings for Organon ↗

November 03, 2023

Via Benzinga

Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 21, 2023

From Organon & Co.

Via Business Wire

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

December 18, 2023

From Organon & Co.

Via Business Wire

Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts ↗

December 12, 2023

Via Benzinga

Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits ↗

December 05, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

November 27, 2023

Via Benzinga

Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True? ↗

November 21, 2023

High-yielding stocks may be tantalizing, but they often come with risks.

Via The Motley Fool

Organon To Present at the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

From Organon & Co.

Via Business Wire

Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts ↗

November 09, 2023

Via Benzinga

Samsung Bioepis & Organon Announce FDA Acceptance of Supplemental Biologics License Application (sBLA) for Interchangeability Designation for HADLIMA™ (adalimumab-bwwd), a Biosimilar to Humira®

November 07, 2023

From Samsung Bioepis

Via GlobeNewswire

Organon Reports Results for the Third Quarter Ended September 30, 2023

November 02, 2023

From Organon & Co.

Via Business Wire

Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed

November 01, 2023

From Organon & Co.

Via Business Wire

A Look Into Healthcare Sector Value Stocks ↗

October 30, 2023

Via Benzinga

Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023

October 19, 2023

From Organon & Co.

Via Business Wire

Lululemon Athletica Races to New High with S&P 500 Entry

October 17, 2023

Lululemon's stock soared 10.31%, its best level since late 2021, upon joining the S&P 500, replacing Activision Blizzard. The change is effective October 18.

Via MarketBeat

Topics Stocks

Lululemon Athletica To Join S&P 500 Index; LULU Stock Flashes Buy Signal ↗

October 13, 2023

The yoga retailer will join the index before Wednesday's open.

Via Investor's Business Daily

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice

September 27, 2023

From Organon & Co.

Via Business Wire

5 Value Stocks To Watch In The Healthcare Sector ↗

September 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023 ↗

September 21, 2023

Via Benzinga

First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology

September 14, 2023

From Organon & Co.

Via Business Wire

3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗

September 09, 2023

Viatris, GSK, and Organon are all trading at less than 7 times earnings.

Via The Motley Fool

Stock Analysis: Organon & Co. ↗

September 07, 2023

Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide.

Via Talk Markets

Organon Bolsters Research & Development Expertise with Two Leadership Appointments

September 05, 2023

From Organon & Co.

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.